Fox Run Management’s Krystal Biotech KRYS Stock Holding History

Fox Run Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$424K	Buy
2024 Q4	$339K	Buy
2024 Q1	–	Sell
2023 Q4	$426K	Buy
2023 Q3	$219K	Buy